Table of Contents

1. Introduction
 1.1 Market Definition & Scope
 1.2 Research Assumptions & Abbreviations
 1.3 Research Methodology

2. Executive Summary
 2.1 Market Snapshot
 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2035
 2.3 Market Size & Forecast, By Segmentation, 2022 – 2035
  2.3.1 Market Size By Application
  2.3.2 Market Size By Technology
  2.3.3 Market Size By Delivery Method
  2.3.4 Market Size By End-Use
 2.4 Market Share & Bps Analysis By Region, 2025
 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
 2.6 Industry CxO's Perspective

3. Market Overview
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Key Market Trends
 3.2 Industry PESTLE Analysis
 3.3 Key Industry Forces (Porter's) Impacting Market Growth
 3.4 Industry Supply Chain Analysis
  3.4.1 Technology Developers & Tool Providers
  3.4.2 Reagent & Kit Manufacturers
  3.4.3 Biotechnology Companies, Pharmaceutical Firms, Research Institutes (End-Users)
  3.4.4 Patients & Agricultural Producers (End Beneficiaries)
 3.5 Industry Life Cycle Assessment
 3.6 Parent Market Overview (Life Sciences Tools & Services)
 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting
 4.1 Clinical Development & Therapeutic Metrics
  4.1.1 Overview
  4.1.2 Gene Therapy Clinical Trial Initiation Rates by Technology
  4.1.3 Regulatory Approval Timeline Analysis for Gene-Edited Therapeutics
  4.1.4 Patient Enrollment Trends in Genome Editing Clinical Studies
  4.1.5 Therapeutic Indication Distribution (Oncology vs. Rare Diseases vs. Others)

 4.2 Technology Adoption & Innovation Metrics
  4.2.1 Overview
  4.2.2 CRISPR Technology Patent Filing & Licensing Activity
  4.2.3 Base Editing & Prime Editing Research Publication Trends
  4.2.4 Delivery System Development Progress (Viral vs. Non-Viral)
  4.2.5 Artificial Intelligence Integration in Guide RNA Design

 4.3 Research & Development Investment Metrics
  4.3.1 Overview
  4.3.2 Venture Capital Investment in Gene Editing Startups
  4.3.3 Pharmaceutical Company R&D Spending on Genetic Medicine
  4.3.4 Government Funding Allocation for Genome Editing Research
  4.3.5 Academic-Industry Collaboration Partnership Rates

 4.4 Agricultural & Industrial Application Metrics
  4.4.1 Overview
  4.4.2 Gene-Edited Crop Variety Approval Rates by Country
  4.4.3 Agricultural Yield Improvement Performance Data
  4.4.4 Livestock Genetic Modification Project Trends
  4.4.5 Industrial Biotechnology Application Expansion Rates

5. Genome Editing Market Segmental Analysis & Forecast, By Application, 2022 – 2035, Value (USD Billion)
 5.1 Introduction
 5.2 Genetic Engineering
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
  5.2.3 Cell Line Engineering
  5.2.4 Animal Genetic Engineering
  5.2.5 Plant Genetic Engineering
  5.2.6 Others
 5.3 Clinical Applications
  5.3.1 Diagnostics Development
  5.3.2 Therapy Development

6. Genome Editing Market Segmental Analysis & Forecast, By Technology, 2022 – 2035, Value (USD Billion)
 6.1 Introduction
 6.2 CRISPR/Cas9
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022 – 2035
 6.3 TALENs/MegaTALs
 6.4 ZFN
 6.5 Meganuclease
 6.6 Others

7. Genome Editing Market Segmental Analysis & Forecast, By Delivery Method, 2022 – 2035, Value (USD Billion)
 7.1 Introduction
 7.2 Ex-vivo
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022 – 2035
 7.3 In-vivo

8. Genome Editing Market Segmental Analysis & Forecast, By End-Use, 2022 – 2035, Value (USD Billion)
 8.1 Introduction
 8.2 Biotechnology and Pharmaceutical Companies
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, 2022 – 2035
 8.3 Academic and Government Research Institutes
 8.4 Contract Research Organizations

9. Genome Editing Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)
 9.1 Introduction
 9.2 North America
  9.2.1 Key Trends
  9.2.2 Genome Editing Market Size & Forecast, By Application, 2022 – 2035
  9.2.3 Genome Editing Market Size & Forecast, By Technology, 2022 – 2035
  9.2.4 Genome Editing Market Size & Forecast, By Delivery Method, 2022 – 2035
  9.2.5 Genome Editing Market Size & Forecast, By End-Use, 2022 – 2035
  9.2.6 Genome Editing Market Size & Forecast, By Country, 2022 – 2035
   9.2.6.1 USA
   9.2.6.2 Canada

 9.3 Europe
  9.3.1 Key Trends
  9.3.2 Genome Editing Market Size & Forecast, By Application, 2022 – 2035
  9.3.3 Genome Editing Market Size & Forecast, By Technology, 2022 – 2035
  9.3.4 Genome Editing Market Size & Forecast, By Delivery Method, 2022 – 2035
  9.3.5 Genome Editing Market Size & Forecast, By End-Use, 2022 – 2035
  9.3.6 Genome Editing Market Size & Forecast, By Country, 2022 – 2035
   9.3.6.1 Germany
   9.3.6.2 UK
   9.3.6.3 France
   9.3.6.4 Italy
   9.3.6.5 Spain
   9.3.6.6 Russia
   9.3.6.7 Poland
   9.3.6.8 Rest of Europe

 9.4 Asia-Pacific
  9.4.1 Key Trends
  9.4.2 Genome Editing Market Size & Forecast, By Application, 2022 – 2035
  9.4.3 Genome Editing Market Size & Forecast, By Technology, 2022 – 2035
  9.4.4 Genome Editing Market Size & Forecast, By Delivery Method, 2022 – 2035
  9.4.5 Genome Editing Market Size & Forecast, By End-Use, 2022 – 2035
  9.4.6 Genome Editing Market Size & Forecast, By Country, 2022 – 2035
   9.4.6.1 China
   9.4.6.2 India
   9.4.6.3 Japan
   9.4.6.4 South Korea
   9.4.6.5 Australia
   9.4.6.6 ASEAN Countries
   9.4.6.7 Rest of Asia-Pacific

 9.5 Latin America
  9.5.1 Key Trends
  9.5.2 Genome Editing Market Size & Forecast, By Application, 2022 – 2035
  9.5.3 Genome Editing Market Size & Forecast, By Technology, 2022 – 2035
  9.5.4 Genome Editing Market Size & Forecast, By Delivery Method, 2022 – 2035
  9.5.5 Genome Editing Market Size & Forecast, By End-Use, 2022 – 2035
  9.5.6 Genome Editing Market Size & Forecast, By Country, 2022 – 2035
   9.5.6.1 Brazil
   9.5.6.2 Argentina
   9.5.6.3 Mexico
   9.5.6.4 Colombia
   9.5.6.5 Rest of Latin America

 9.6 Middle East & Africa
  9.6.1 Key Trends
  9.6.2 Genome Editing Market Size & Forecast, By Application, 2022 – 2035
  9.6.3 Genome Editing Market Size & Forecast, By Technology, 2022 – 2035
  9.6.4 Genome Editing Market Size & Forecast, By Delivery Method, 2022 – 2035
  9.6.5 Genome Editing Market Size & Forecast, By End-Use, 2022 – 2035
  9.6.6 Genome Editing Market Size & Forecast, By Country, 2022 – 2035
   9.6.6.1 UAE
   9.6.6.2 Saudi Arabia
   9.6.6.3 Qatar
   9.6.6.4 Egypt
   9.6.6.5 South Africa
   9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape
 10.1 Key Players' Positioning
 10.2 Competitive Developments
  10.2.1 Key Strategies Adopted (%), By Key Players, 2025
  10.2.2 Year-Wise Strategies & Development, 2021 – 2025
  10.2.3 Number Of Strategies Adopted By Key Players, 2025
 10.3 Market Share Analysis, 2025
 10.4 Product/Service & Application Benchmarking
  10.4.1 Product/Service Specifications & Features By Key Players
  10.4.2 Product/Service Heatmap By Key Players
  10.4.3 Application Heatmap By Key Players
 10.5 Industry Start-Up & Innovation Landscape
 10.6 Key Company Profiles
  10.6.1 Thermo Fisher Scientific Inc.
   10.6.1.1 Company Overview & Snapshot
   10.6.1.2 Product/Service Portfolio
   10.6.1.3 Key Company Financials
   10.6.1.4 SWOT Analysis
  10.6.2 CRISPR Therapeutics AG
  10.6.3 Editas Medicine, Inc.
  10.6.4 Intellia Therapeutics, Inc.
  10.6.5 Beam Therapeutics Inc.
  10.6.6 Sangamo Therapeutics, Inc.
  10.6.7 Horizon Discovery Group (Revvity)
  10.6.8 GenScript Biotech Corporation
  10.6.9 Merck KGaA
  10.6.10 Lonza Group AG
  10.6.11 Precision BioSciences, Inc.
  10.6.12 Bluebird Bio, Inc.
  10.6.13 Caribou Biosciences, Inc.
  10.6.14 Cellectis S.A.
  10.6.15 Integrated DNA Technologies (IDT)
  10.6.16 New England Biolabs, Inc.
  10.6.17 OriGene Technologies, Inc.
  10.6.18 Synthego Corporation
  10.6.19 Regeneron Pharmaceuticals, Inc.

11. Analyst Recommendations
 11.1 SNS Insider Opportunity Map
 11.2 Industry Low-Hanging Fruit Assessment
 11.3 Market Entry & Growth Strategy
 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix
 14.1 List Of Tables
 14.2 List Of Figures